Shock priming enhances the efficacy of SSRIs in the foot shock-induced ultrasonic vocalization test

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 36, Issue 1, 2012, Pages 128-135

  Kassai, Ferenc ^a   Gyertyán, István ^a  

^a GEDEON RICHTER LTD   (Hungary)

Author keywords

Anxiety; Rat; Selective serotonin reuptake inhibitor; Ultrasonic vocalization

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ALPRAZOLAM; ESCITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG INHIBITION; FOOTSHOCK; MALE; NONHUMAN; RAT; SHOCK; TRANQUILIZING ACTIVITY; VOCALIZATION;

ANIMALS; ANXIETY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; MALE; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; SOUND; TREATMENT OUTCOME; VOCALIZATION, ANIMAL;

EID: 82555176503     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.10.012     Document Type: Article

References (32)

1. Andó R.D., Ádori C., Kirilly E., Molnár E., Kovács G.G., Ferrington L., et al. Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion. Behav Brain Res 2010, 207:280-289.
2. Antoniadis E.A., McDonald R.J. Fornix, medial prefrontal cortex, nucleus accumbens, and mediodorsal thalamic nucleus: roles in a fear-based context discrimination task. Neurobiol Learn Mem 2006, 85:71-85.
3. Bagdy G., Graf M., Anheuer Z.E., Modos E.A., Kantor S. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 2001, 4:399-408.
4. Bartoszyk G.D., Hegenbart R., Ziegler H. EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT receptor agonistic properties. Eur J Pharmacol 1997, 332:147-153.
5. Bertaina-Anglade V., Enjuanes E., Morillon D., Drieu la Rochelle C. The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity. J Pharmacol Toxicol Methods 2009, 54:99-105.
6. Dazzi L., Seu E., Cherchi G., Biggio G. Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress. Eur Neuropsychopharmacol 2005, 15:283-290.
7. De Vry J., Benz U., Schreiber R., Traber J. Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs. Eur J Pharmacol 1993, 249:331-339.
8. 1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. Eur Neuropsychopharmacol 2004, 14:487-495.
9. 2C receptors. Neuropharmacology 2000, 39:1114-1117.
10. Egashira N., Matsumoto Y., Mishima K., Iwasaki K., Fujioka M., Matsushita M., et al. Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization. Pharmacol Biochem Behav 2006, 83:161-167.
11. Hale M.W., Shekhar A., Lowry C.A. Development by environment interactions controlling tryptophan hydroxylase expression. J Chem Neuroanat 2011, 41:219-226.
12. Hodgson R.A., Guthrie D.H., Varty G.B. Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: sensitivity to anxiolytic and antidepressant drugs. Pharmacol Biochem Behav 2008, 88:341-348.
13. Hogan J.B., Hodges D.B., Lelas S., Gilligan P.J., McElroy J.F., Lindner M.D. Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests. Psychopharmacology (Berl) 2005, 178:410-419.
14. 2A receptor-mediated behavior in rats after a single footshock. Eur J Pharmacol 2002, 452:199-204.
15. Jelen P., Soltysik S., Zagrodzka J. 22-kHz ultrasonic vocalization in rats as an index of anxiety but not fear: behavioral and pharmacological modulation of affective state. Behav Brain Res 2003, 141:63-72.
16. 1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?. J Pharmacol Exp Ther 1995, 272:920-929.
17. 1A receptor messenger RNA regulation in the hippocampus after acute stress. Biol Psychiatry 1999, 45:934-937.
18. Molewijk H.E., van der Poel A.M., Mos J., van der Heyden J.A., Olivier B. Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs. Psychopharmacology 1995, 117:32-40.
19. Monleon S., Vinader-Caerols C., Arenas M.C., Parra A. Antidepressant drugs and memory: insights from animal studies. Eur Neuropsychopharmacol 2008, 18:235-248.
20. 1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in conditioned fear stress in the rat. Eur J Pharmacol 2008, 586:171-178.
21. Nishikawa H., Inoue T., Izumi T., Koyama T. Synergistic effects of tandospirone and selective serotonin reuptake inhibitors on the contextual conditioned fear stress response in rats. Eur Neuropsychopharmacol 2007, 17:643-650.
22. Pawlak D., Takada Y., Urano T., Takada A. Serotonergic and kynurenic pathways in rats exposed to foot shock. Brain Res Bull 2000, 52:197-205.
23. Sanchez C. Effect of serotonergic drugs on footshock-induced ultrasonic vocalization in adult male rats. Biochem Pharmacol 1993, 4:269-277.
24. Sanchez C. R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model. Eur J Pharmacol 2003, 464:155-158.
25. Sanchez C. Stress-induced vocalisation in adult animals. A valid model of anxiety?. Eur J Pharmacol 2003, 463:133-143.
26. Sanchez C., Meier E. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Psychopharmacology 1997, 129:195-205.
27. 2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats. Eur Neuropsychopharmacol 1999, 9:287-294.
28. Sanchez C., Bergqvist P.B., Brennum L.T., Gupta S., Hogg S., Larsen A., et al. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology 2003, 167:353-362.
29. Schreiber R., Melon C., De Vry J. The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test. Psychopharmacology 1998, 135:383-391.
30. Silva R.C.B., Brandao M.L. Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol Biochem Behav 2000, 65:209-216.
31. Stark H., Scheich H. Dopaminergic and serotonergic neurotransmission systems are differentially involved in auditory cortex learning: a long-term microdialysis study of metabolites. J Neurochem 1997, 68:691-697.
32. 1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test. Neuropsychopharmacology 2007, 32:2163-2172.